In mid-morning trading the FTSE 100 is down 75 points at 6698 as household names like Tate & Lyle and Tesco lead the market lower.
In London, the FTSE has just dipped below the 6700 mark. Tesco is still the talk of the town for all the wrong reasons. The troubled supermarket giant has drafted in Alan Stewart as the new CFO; Mr Stewart was originally due to take up the post in December but desperate times call for desperate measures, as the stock is off 2.5%. Foods company Tate & Lyle is also far from flavour of the month after issuing a profit warning. Increased competition and supply chain issues were cited as reasons for the poor performance. Mothercare has announced a £100 million rights issue to help finance the mother of all comebacks, with the aim to reduce its presence on the high street and focus on the online business. Tougher tax laws introduced by the US, to prevent companies from dodging high taxation levels by locating their headquarters overseas, has hurt AstraZeneca and Shire Pharmaceutical.
Mining companies have breathed a sigh of relief, as the HSBC survey of Chinese manufacturing revealed a surprise jump in output in September. Traders were preparing themselves for underwhelming numbers, and judging by the small bounce in mineral extractors this could be the calm before the next wave of selling.
In the US, we are calling the Dow down 30 points at 17,142. US index futures are being dragged lower by sentiment in Europe.
In London, the FTSE has just dipped below the 6700 mark. Tesco is still the talk of the town for all the wrong reasons. The troubled supermarket giant has drafted in Alan Stewart as the new CFO; Mr Stewart was originally due to take up the post in December but desperate times call for desperate measures, as the stock is off 2.5%. Foods company Tate & Lyle is also far from flavour of the month after issuing a profit warning. Increased competition and supply chain issues were cited as reasons for the poor performance. Mothercare has announced a £100 million rights issue to help finance the mother of all comebacks, with the aim to reduce its presence on the high street and focus on the online business. Tougher tax laws introduced by the US, to prevent companies from dodging high taxation levels by locating their headquarters overseas, has hurt AstraZeneca and Shire Pharmaceutical.
Mining companies have breathed a sigh of relief, as the HSBC survey of Chinese manufacturing revealed a surprise jump in output in September. Traders were preparing themselves for underwhelming numbers, and judging by the small bounce in mineral extractors this could be the calm before the next wave of selling.
In the US, we are calling the Dow down 30 points at 17,142. US index futures are being dragged lower by sentiment in Europe.
Recommended Content
Editors’ Picks
AUD/USD: Extra gains in the pipeline above 0.6520
AUD/USD partially reversed Tuesday’s strong pullback and regained the 0.6500 barrier and beyond in response to the sharp post-FOMC pullback in the Greenback on Wednesday.
EUR/USD meets support around 1.0650
EUR/USD managed to surpass the key 1.0700 barrier in response to the intense retracement in the US Dollar in the wake of the Fed’s interest rate decision and Chair Powell’s press conference.
Gold surpasses $2,300 as Dollar tumbles
The precious metal maintains its constructive stance and trespasses the $2,300 region on Wednesday after the Federal Reserve left its FFTR intact, matching market expectations.
Bitcoin price reclaims $59K as Fed leaves rates unchanged
The market was at the edge of its seat on Wednesday to see whether the US Federal Reserve (Fed) would cut interest rates during the Federal Open Market Committee (FOMC) meeting.
The market welcomes the Fed's statement
The market has welcomed the Fed statement, and the S&P 500 is higher in its aftermath, the dollar is lower and Treasury yields are falling. There is still only one cut priced in by the Fed.